Our transplant program means access to a program with top survival outcomes, innovative research, a personal transplant team, and rapid clinical evaluations.

When a patient has developed one or more NYHA stage D criteria:

• Persistent significant symptoms
• Unable to walk on a level surface without stopping
• Recurrent emergency department or unscheduled clinic visits for heart failure (>2 in the past year)
• Unable to tolerate or need to be removed from HF therapy (ACEI, ARB, beta-blocker)
• Renal insufficiency or hyponatremia
• Need for intermittent or continuous inotropes
• Recurrent hospitalization for heart failure (>2 in past year)
• Abnormal hemodynamics (low cardiac output, elevated pulmonary pressures, or persistent volume overload)
• Need for high diuretic doses (80 mg or greater of furosemide or equivalent)
• Unexplained weight loss (cardiac cachexia)